Pressure-Overload Cardiac Hypertrophy Is Associated with Distinct Alternative Splicing Due to Altered Expression of Splicing Factors|RISS 상세보기

다국어 초록 (Multilingual Abstract)

Chronic pressure-overload cardiac hypertrophy is associated with an increased risk of morbidity/mortality, largely due to maladaptive remodeling and dilatation that pro-gresses to dilated cardiomyopathy. Alternative splicing is an important biological mechanism that generates proteomic complexity and diversity. The recent development of next-generation RNA sequencing has improved our understanding of the qualitative signatures associated with alternative splicing in various biological conditions. However, the role of alternative splicing in cardiac hypertrophy is yet unknown. The present study employed RNA-Seq and a bioinformatic approach to detect the RNA splicing regulatory elements involved in alternative splicing during pressure-overload cardiac hypertrophy. We found GC-rich exonic motifs that regulate intron retention in 5 UTRs and AT-rich exonic motifs that are involved in exclusion of the AT-rich elements that cause mRNA instability in 3 UTRs. We also identified motifs in the intronic regions involved in exon exclusion and inclusion, which predicted splicing factors that bind to these motifs. We found, through Western blotting, that the expression levels of three splicing factors, ESRP1, PTB and SF2/ASF, were significantly altered during cardiac hypertrophy. Collec-tively, the present results suggest that chronic pressure-overload hypertrophy is closely associated with distinct alternative splicing due to altered expression of splicing factors.

번역하기

참고문헌 (Reference)

1 Lim, K. H., "Using positional distribution to identify splicing elements and predict pre-mRNA processing defects in human genes" 108 : 11093-11098, 2011

2 Taft, R. J., "The relationship between non-protein-coding DNA and eukaryotic complexity" 29 : 288-299, 2007

3 Ladd, A. N., "The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing" 21 : 1285-1296, 2001

4 Jianhua Zhou, "Targeting RNA-Splicing for SMA Treatment" 한국분자세포생물학회 33 (33): 223-228, 2012

5 Reinke, L. M., "Snail represses the splicing regulator epithelial splicing regulatory protein 1 to promote epithelial-mesenchymal transition" 287 : 36435-36442, 2012

6 Ames, E. G., "Sequencing of mRNA identifies re-expression of fetal splice variants in cardiac hypertrophy" 62 : 99-107, 2013

7 Huh, G. S., "Regulation of alternative premRNA splicing by a novel repeated hexanucleotide element" 8 : 1561-1574, 1994

8 Ren, S., "RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings" 22 : 806-821, 2012

9 Eswaran, J., "RNA sequencing of cancer reveals novel splicing alterations" 3 : 1689-, 2013

10 Fairbrother, W. G., "Predictive identification of exonic splicing enhancers in human genes" 297 : 1007-1013, 2002